MATTHEW HEBDEN PORTEUS, MD
Medical Practice at Harry Hines Blvd, Dallas, TX
License number
Texas L6581
Category
Medical Practice
Type
Pediatric Hematology-Oncology
Address
Address
5323 Harry Hines Blvd, Dallas, TX 75390
Phone
(214) 730-5437
Professional information
Physician/Scientist At Utsw
Position:
Physician/Scientist at UTSW
Location:
Dallas/Fort Worth Area
Industry:
Medical Practice
Work:
UTSW
-
Physician/Scientist
Dr. Matthew H Porteus, Dallas TX - MD (Doctor of Medicine)
Specialties:
Pediatric Hematology & Oncology
Address:
1935 Medical District Dr, Dallas 75235
(214) 456-2382 (Phone)
(214) 456-2382 (Phone)
Certifications:
Pediatric Oncology & Pediatric Hematology, 2000, Pediatrics, 1999
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Stanford University School Of Medicine
Graduated: 1994
Children's Hospital Boston
Graduated: 1995
Graduated: 1996
Chldns Hospital Dana Farber Canc Institute
Graduated: 1999
Stanford University School Of Medicine
Graduated: 1994
Children's Hospital Boston
Graduated: 1995
Graduated: 1996
Chldns Hospital Dana Farber Canc Institute
Graduated: 1999
Matthew Hebden Porteus, Dallas TX
Specialties:
Pediatric Hematologist / Oncologist
Address:
5323 Harry Hines Blvd, Dallas, TX 75390
Education:
Stanford University, School of Medicine - Doctor of Medicine
Stanford University, School of Medicine - Doctor of Philosophy
Stanford University, School of Medicine - Doctor of Philosophy
Board certifications:
American Board of Pediatrics Sub-certificate in Pediatric Hematology/Oncology (Pediatrics)
Use Of Chimeric Nucleases To Stimulate Gene Targeting
US Patent:
2005002, Feb 3, 2005
Filed:
Sep 5, 2003
Appl. No.:
10/656531
Inventors:
David Baltimore - Pasadena CA, US
Matthew Porteus - Dallas TX, US
Matthew Porteus - Dallas TX, US
International Classification:
C12Q001/68, C07H021/04, C12N009/22
US Classification:
435006000, 435069100, 435199000, 435320100, 435325000, 536023200
Abstract:
Gene targeting is a technique to introduce genetic change into one or more specific locations in the genome of a cell. For example, gene targeting can introduce genetic change by modifying, repairing, attenuating or inactivating a target gene or other chromosomal DNA. In one aspect, this disclosure relates to methods and compositions for gene targeting with high efficiency in a cell. This disclosure also relates to methods of treating or preventing a genetic disease in an individual in need thereof. Further disclosed are chimeric nucleases and vectors encoding chimeric nucleases.